Article Publish Status: FREE
Abstract Title:

Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population.

Abstract Source:

Pathogens. 2021 Jun 4 ;10(6). Epub 2021 Jun 4. PMID: 34199852

Abstract Author(s):

Ana Méndez-Echevarría, Talía Sainz, Iker Falces-Romero, Beatriz de Felipe, Lucia Escolano, Sonia Alcolea, Lidia Pertiñez, Olaf Neth, Cristina Calvo

Article Affiliation:

Ana Méndez-Echevarría


BACKGROUND: Antibody dynamics over time after SARS-CoV-2 infection are still unclear, and data regarding children are scarce.

METHODS: A prospective cohort study was performed including children infected by SARS-CoV-2 between March and May 2020. Patients were categorized into 3 groups: children admitted with COVID-19; outpatient children with mild COVID-19; and seropositive children participating in a seroprevalence study among cohabitants of infected healthcare workers (HCWs). Six months after the infection, a new serological control was performed.

RESULTS: A total of 58 children were included, 50% male (median age 8.3 [IQR 2.8-13.5] years). The median time between the two serological studies was 186 (IQR 176-192) days, and 86% (48/56) of the children maintained positive IgG six months after the infection. This percentage was 100% in admitted patients and 78% among the rest of the included children (= 0.022). The diagnoses of lower respiratory tract infection and multisystemic inflammatory syndrome were associated with persistence of IgG (= 0.035). The children of HCWs in the seroprevalence study lost antibodies more often (= 0.017). Initial IgG titers of the children who remained positive six months after the infection were significantly higher (= 0.008).

CONCLUSIONS: Most children infected by SARS-CoV-2 maintain a positive serological response six months after the infection. Those children who lost their IgG titer were more frequently asymptomatic or mildly symptomatic, presenting with low antibody titers after the infection.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.